Yahoo Web Search

  • FirefoxTry Yahoo Search on Firefox »
    1. Sort by

    1. Houston, TX, Aug. 27, 2015-- Viewpoint Molecular Targeting LLC. and RadioMedix Inc. partnership resulted in the second Small Business Innovation Research Grant awarded by the National Institutes of Health, ...

    2. Ocata Therapeutics, Inc. , a leader in the field of Regenerative Ophthalmology™, today announced that it has been awarded a Small Business Innovation Research Phase 1 grant from the National Institute of Allergy and Infectious Diseases , part of the National Institutes of Health , to fund further preclinical development of Ocata’s proprietary Hemangio-derived Mesenchymal Cell product for the ...

    3. C4 Imaging Awarded $1.3 Million NIH SBIR Phase II Grant

      PR Newswire via Yahoo! FinanceAug 21 06:30 AM

      HOUSTON, Aug. 21, 2015 /PRNewswire/ -- C4 Imaging LLC today announced it has been awarded a $1.32 Million Phase II Small Business Innovation Research ("SBIR") grant from the National Cancer Institute ...

    4. August 18, 2015 SBIR/STTR FY16 Phase 1 Release 1 Topics Announced—Includes Hydrogen Production and Fuel Cell Membrane Topics The U.S. Department of Energy has announced the 2016 Small Business Innovation Research and Small Business Technology Transfer ( SBIR/STTR) Phase I Release 1 Topics, including hydrogen production from organic waste streams and fuel cell membranes, through the Office of ...

    5. Chrono Therapeutics, a pioneer in digital drug therapy, today announced it has received a second Phase 1 and Phase 2 Fast Track Small Business Innovation Research (SBIR) grant award from the National Cancer Institute.

    6. SAN FRANCISCO, Aug. 26, 2015 /PRNewswire/ -- Platform therapeutic company Symic Biomedical, Inc. ("Symic") announced today that it has received a $1.5M Phase II SBIR grant from the National Institutes of Health (NIH) to further develop its therapeutic agent to reduce arteriovenous fistula (AVF) failures, a significant unmet clinical need in end stage renal disease (ESRD) patients undergoing ...

    7. HAYWARD, Calif., Aug. 25, 2015 /PRNewswire/ -- Chrono Therapeutics, a pioneer in digital drug therapy, today announced it has received a second Phase 1 and Phase 2 Fast Track Small Business Innovation Research (SBIR) grant award from the National Cancer Institute (NCI). This award of up to $2.3 million will support final product development of the digital portion of Chrono's patient ...

    8. ROCHESTER, N.Y., Aug. 20, 2015 /PRNewswire-USNewswire/ -- The U.S. Department of Energy (DOE) this week released its 2016 SBIR/STTR Phase I Release I Funding Opportunity Announcement (FOA). To view the FOA and corresponding deadlines, visit...

    9. Platform therapeutic company Symic Biomedical, Inc. announced today that it has received a $1.5M Phase II SBIR grant from the National Institutes of Health to further develop its therapeutic agent to reduce arteriovenous fistula (AVF) failures, a significant unmet clinical need in end stage renal disease (ESRD) patients undergoing hemodialysis.

    10. Generation Orbit Launch Services, Inc. (GO) has been awarded a Phase II Small Business Innovative Research (SBIR) contract from the Air Force Research Laboratory, Aerospace Systems Directorate (AFRL/RQ) for continued development of the GOLauncher 1.

    1. 1234567 results